| Literature DB >> 28544401 |
Wen-Hsuan Tseng1, Chung-Ke Chang2, Pei-Ching Wu1, Nien-Jen Hu3, Gene-Hsiang Lee4, Ching-Cherng Tzeng5, Stephen Neidle6, Ming-Hon Hou1,7.
Abstract
Small-molecule compounds targeting trinucleotide repeats in DNA have considerable potential as therapeutic or diagnostic agents against many neurological diseases. NiII (Chro)2 (Chro=chromomycin A3) binds specifically to the minor groove of (CCG)n repeats in duplex DNA, with unique fluorescence features that may serve as a probe for disease detection. Crystallographic studies revealed that the specificity originates from the large-scale spatial rearrangement of the DNA structure, including extrusion of consecutive bases and backbone distortions, with a sharp bending of the duplex accompanied by conformational changes in the NiII chelate itself. The DNA deformation of CCG repeats upon binding forms a GGCC tetranucleotide tract, which is recognized by NiII (Chro)2 . The extruded cytosine and last guanine nucleotides form water-mediated hydrogen bonds, which aid in ligand recognition. The recognition can be accounted for by the classic induced-fit paradigm.Entities:
Keywords: DNA deformation; X-ray crystallography; induced-fit recognition; neurological disease; trinucleotide repeats
Mesh:
Substances:
Year: 2017 PMID: 28544401 DOI: 10.1002/anie.201703989
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336